Navigation Links
MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting

isone and in 10% of patients treated with irofulven + prednisone. No PSA responses were observed following treatment with mitoxantrone + prednisone. Treatment related toxicity including Grade 3-4 myelosuppression was manageable in all 3 arms. These results support further study of irofulven in this setting.

Additional Abstracts Presented at the 2007 ASCO Annual Meeting

Abstract # 7080

"Changing the treatment paradigm for patients with MDS: how the development of therapeutics influences population-based care in community oncology - the Georgia Cancer Specialists Outcomes Database experience"

Abstract # 7088

"Phase II trial of decitabine in myelofibrosis with myeloid metaplasia"

Abstract # 9565

"Decitabine (DAC) in combination with doxorubicin (DOX) and cyclophosphamide (CTX) in relapsed neuroblastoma (NBL): A Children's Oncology Group Study"

Abstract # 2036

"Phase II trial of Gliadel plus O6-benzylguanine (O6-BG) for patients with recurrent glioblastoma multiforme"

Abstract #34157

"A retrospective safety and efficacy analysis of combination therapy for GBM using temozolomide, external beam radiation (EBRT), and Gliadel Wafers"

About Aloxi(R) Injection

Aloxi is approved for the prevention of acute nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy and for the prevention of delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. Aloxi is the first and only 5-HT3 receptor antagonist to be indicated for the prevention of delayed chemotherapy-induced nausea and vomiting (CINV) caused by moderately emetogenic cancer chemotherapy. In clinical trials, the most common adverse reactions related to Aloxi were headache (9%) and constipation (5%). Aloxi is contraindicated in patients known to have hypersensitivity to the drug or any of its components. Please see t
'"/>




Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. MGI Pharma Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
5. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
8. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
9. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
10. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
11. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
Post Your Comments:
(Date:6/1/2015)... LA JOLLA, Calif. , June 1, 2015 ... RGLS ), a biopharmaceutical company leading the discovery ... today that Kleanthis G. Xanthopoulos , Ph.D. ... and as a member of Regulus, Board of ... the biotechnology industry.  Paul Grint, M.D., who previously ...
(Date:6/1/2015)... , June 1, 2015 ... weight over large area and improve the quality life ... ulcer. These devices play a significant role in inhibiting ... reduce the need to turn or rotate an immobile ... include mattress, mattresses overlay, and specialty beds. These devices ...
(Date:6/1/2015)... June 1, 2015 NEOVIA ONCOLOGY Ltd. ... in the development and commercialization of novel, multi-function ... has met with the U.S. Food and Drug ... of an Investigational New Drug (IND) application for ... result of the meeting, Neovia has clarified details ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Neovia Oncology Announces First IND Meeting 2
... TechPrecision Corporation (OTC Bulletin Board: TPCS ... precision, large-scale fabricated and machined metal components and systems ... cleantech , medical , nuclear , defense ... that its Wuxi Critical Mechanical Components Co., Ltd. (WCMC), subsidiary ...
... 2011    Advanced Biologics, ( www.advancedbiologics.com ) announced ... product within the OsteoAMP ® platform during ... this week in Chicago, IL.  OsteoAMP Structural is ... demonstrates osteoinductive properties in-vivo.  Initial product offerings will ...
Cached Medicine Technology:TechPrecision Corporation's WCMC Division Adds Second Sapphire Customer 2TechPrecision Corporation's WCMC Division Adds Second Sapphire Customer 3Advanced Biologics Launches OsteoAMP® Structural at the 26th Annual Meeting of the North American Spine Society 2
(Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Selma Tansey as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... exclusively for professional women, boasting more than 700,000 members ... to present Selma with this important honor," said NAPW ...
(Date:6/1/2015)... June 01, 2015 Carson Energy also ... their investors IRA transactions. AdvantaIRA Trust, LLC is the ... the ability to fund positions using IRA’s does 2 ... on a project, even if there current cash position ... additional funding source for Carson and their investors to ...
(Date:6/1/2015)... Texas (PRWEB) June 01, 2015 Unlike most ... as three times for in-use periods compared to when the ... monthly rate whether the client uses the generator or not. ... availability and delivery in as little as a few hours ... desire to store a portable generator onsite. , “Even minor ...
(Date:6/1/2015)... Linda Kincaid, age 67, knew something was wrong. She ... she thought it was just a part of getting older, ... that. After going to the doctor, she received a distressing ... what might happen to her. , Linda is not alone. ... disease each year. Valve disease involves damage to one or ...
(Date:6/1/2015)... The Muscular Dystrophy Association is ... participating in the sold out 2015 Bank of ... guaranteed entry by signing up through the organization's ... is limited. , This national endurance program includes ... abilities, and a supportive community of teammates, volunteers, ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Selma Tansey, Executive Director of Washington Communities Human Services, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Worldwide Power Products Offers “Budget Billing” Contingency Generator Rental Program; Guarantees Power for Peak of Hurricane Season and Beyond 2Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3Health News:Sold Out 2015 Bank of America Chicago Marathon and Marine Corps Marathon Entries Still Available through MDA Team Momentum 2
... HealthDay Reporter , TUESDAY, Oct. 5 (HealthDay News) -- ... risk for heart disease, Canadian researchers say. ... which by itself is a risk factor for heart disease, ... workplace is an important occupational health issue, especially for younger ...
... veterans until old age, even as it influences others to be ... University of Florida study finds. The findings are ominous with ... the ongoing Iraq and Afghanistan wars on terror at a rate ... World War II, said UF sociologist Monika Ardelt. "The study ...
... Oct. 6, 2010 A set of proteins found in ... to diagnose Alzheimer,s disease, researchers at UT Southwestern Medical Center ... An analysis of the proteins, plus a clinical exam, proved ... accurate in ruling it out in people without the disease, ...
... Reporter , TUESDAY, Oct. 5 (HealthDay News) -- The ... room visits in the United States has tripled since ... dramatic increase in the likelihood of getting a CT ... injury-related conditions without a corresponding increase in the likelihood ...
... The National Institutes of Health has awarded a ... Florida and Tampa-based biotechnology company Saneron-CCEL Therapeutics, Inc., ... human umbilical cord blood cells (HUBC) into animal ... use the pre-clinical data to gain U.S. Food ...
... Center,s Breast Cancer Clinic program has earned a three-year ... Breast Centers (NAPBC), a program administered by the American ... cancer is managed by a team, and the combined ... Christopher O. Ruud, M.D., director of the Scott & ...
Cached Medicine News:Health News:Workplace Noise Tied to Heart Disease Risk 2Health News:Workplace Noise Tied to Heart Disease Risk 3Health News:UF study: Emotional effects of heavy combat can be lifelong for veterans 2Health News:UF study: Emotional effects of heavy combat can be lifelong for veterans 3Health News:Blood test could diagnose Alzheimer's disease, UT Southwestern researchers find 2Health News:MRI, CT Scans for ER Patients Triple Over Decade 2Health News:MRI, CT Scans for ER Patients Triple Over Decade 3Health News:USF and Saneron get $2.6 million to develop Alzheimer's treatment using umbilical cord blood cells 2Health News:Scott & White breast cancer program receives accreditation 2
... hygroscopic condenser humidifiers (HCH) capture the patient`s ... in the inspired gas. Small and compact, ... and hygroscopic benefits. Depending on the tidal ... small-volume model., ,The adult HCH is ...
Combination heat and moisture exchanger and bacterial/viral filters for Anesthesia and Respiratory applications....
HME w/bacterial viral filter w/CO2...
... Thermovent® T helps provide protection to the exposed ... and extremely lightweight making it ideal for active ... high rate of heat and moisture recovery, it ... ,All HMEs and filters have ISO standard tapered ...
Medicine Products: